{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:37:00Z","timestamp":1789472220731,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.brainres.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T04:47:36Z","timestamp":1507870056000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["The heart of PD: Lewy body diseases as neurocardiologic disorders"],"prefix":"10.1016","volume":"1702","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-9940","authenticated-orcid":false,"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehonatan","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.09.033_b0005","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.chemrestox.5b00528","article-title":"Antioxidant-mediated modulation of protein reactivity for 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite","volume":"29","author":"Anderson","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.brainres.2017.09.033_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","article-title":"3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis","volume":"989","author":"Burke","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","article-title":"Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine","volume":"115","author":"Burke","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0025","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.09.033_b0030","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.parkreldis.2014.04.003","article-title":"Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy","volume":"20","author":"Cook","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10787-008-8029-4","article-title":"Bioavailability of olive oil phenolic compounds in humans","volume":"16","author":"de la Torre","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.brainres.2017.09.033_b0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease","volume":"119","author":"Del Tredici","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.24921","article-title":"Lewy pathology and neurodegeneration in premotor Parkinson's disease","volume":"27","author":"Del Tredici","year":"2012","journal-title":"Movement Dis."},{"key":"10.1016\/j.brainres.2017.09.033_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.brainres.2017.09.033_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuro.2006.07.018","article-title":"Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal","volume":"28","author":"Florang","year":"2007","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.brainres.2017.09.033_b0065","doi-asserted-by":"crossref","first-page":"27660","DOI":"10.1074\/jbc.M115.686584","article-title":"Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of alpha-synuclein with the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL)","volume":"290","author":"Follmer","year":"2015","journal-title":"J Biol Chem."},{"key":"10.1016\/j.brainres.2017.09.033_b0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.21989","article-title":"Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease","volume":"23","author":"Fujishiro","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","article-title":"Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity","volume":"123","author":"Gaugler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004872-199105000-00005","article-title":"Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine","volume":"9","author":"Goldstein","year":"1991","journal-title":"J. Hypertens."},{"key":"10.1016\/j.brainres.2017.09.033_b0090","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM199703063361004","article-title":"Sympathetic cardioneuropathy in dysautonomias","volume":"336","author":"Goldstein","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0095","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-135-11-200112040-00026","article-title":"Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein","volume":"135","author":"Goldstein","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0105","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson's disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0120","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.wnl.0000268696.57912.64","article-title":"Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation","volume":"69","author":"Goldstein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10286-007-0396-1","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"17","author":"Goldstein","year":"2007","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10286-009-0002-9","article-title":"Cardiac sympathetic neuroimaging: summary of the First International Symposium","volume":"19","author":"Goldstein","year":"2009","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0b013e3181ca014c","article-title":"Association of anosmia with autonomic failure in Parkinson disease","volume":"74","author":"Goldstein","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0145","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","article-title":"Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases","volume":"121","author":"Goldstein","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2017.09.033_b0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2011.04.011","article-title":"Autonomic dysfunction in PD: a window to early detection?","volume":"310","author":"Goldstein","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2017.09.033_b0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2010.03246.x","article-title":"Catechols in post-mortem brain of patients with Parkinson disease","volume":"18","author":"Goldstein","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/jnc.12766","article-title":"A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson disease","volume":"131","author":"Goldstein","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.09.033_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10286-015-0268-z","article-title":"Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy","volume":"25","author":"Goldstein","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0170","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11064-016-1959-0","article-title":"3,4-Dihydroxyphenylethanol (hydroxytyrosol) mitigates the increase in spontaneous oxidation of dopamine during monoamine oxidase inhibition in PC12 cells","volume":"41","author":"Goldstein","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0175","article-title":"Plasma catechols after eating olives","author":"Goldstein","year":"2017","journal-title":"Clin. Trans. Sci."},{"key":"10.1016\/j.brainres.2017.09.033_b0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2016.12.011","article-title":"Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy","volume":"35","author":"Goldstein","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0185","first-page":"435","article-title":"Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Continuum."},{"key":"10.1016\/j.brainres.2017.09.033_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10571-007-9227-0","article-title":"Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells","volume":"28","author":"Guo","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2017.09.033_b0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s004010050693","article-title":"The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature","volume":"94","author":"Hague","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1076\/jhin.11.1.19.9106","article-title":"Friedrich Heinrich Lewy (1885\u20131950) and his work","volume":"11","author":"Holdorff","year":"2002","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.033_b0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2017.09.033_b0210","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0000000000002102","article-title":"Parkinson disease and incidental Lewy body disease: Just a question of time?","volume":"85","author":"Iacono","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1196\/annals.1410.066","article-title":"Attenuated pre-ejection period response to tyramine in patients with cardiac sympathetic denervation","volume":"1148","author":"Imrich","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2017.09.033_b0220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neures.2009.10.005","article-title":"Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein","volume":"66","author":"Ito","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0225","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"Suppl 6","key":"10.1016\/j.brainres.2017.09.033_b0230","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000314573","article-title":"Importance of 123I-metaiodobenzylguanidine scintigraphy\/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes","volume":"7","author":"Jost","year":"2010","journal-title":"Neurodegener Dis."},{"key":"10.1016\/j.brainres.2017.09.033_b0240","first-page":"1099","article-title":"Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies","volume":"47","author":"Kashihara","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0245","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","article-title":"Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease","volume":"16","author":"Kashihara","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0250","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.parkreldis.2009.01.008","article-title":"Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease","volume":"15","author":"Kim","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0255","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.0b013e31826c1acd","article-title":"Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease","volume":"79","author":"Kim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ene.13206","article-title":"Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?","volume":"24","author":"Kim","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0265","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pscychresns.2009.02.006","article-title":"Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies","volume":"174","author":"Kobayashi","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0275","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.phymed.2007.06.001","article-title":"Bioavailability of the phenolic compounds of the fruits (drupes) of Olea europaea (olives): impact on plasma antioxidant status in humans","volume":"14","author":"Kountouri","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.brainres.2017.09.033_b0280","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U","article-title":"Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde","volume":"60","author":"Lamensdorf","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)02309-X","article-title":"3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells","volume":"868","author":"Lamensdorf","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12883-015-0338-9","article-title":"Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses","volume":"15","author":"Lamotte","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00500085","article-title":"Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives","volume":"332","author":"Laschinski","year":"1986","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2017.09.033_b0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JPD-130333","article-title":"Peripheral autonomic nervous system involvement in Gaucher-related parkinsonism","volume":"4","author":"Lebouvier","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.brainres.2017.09.033_b0305","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/mds.21855","article-title":"The black stuff and Konstantin Nikolaevich Tretiakoff","volume":"23","author":"Lees","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.10236","article-title":"Progressive loss of cardiac sympathetic innervation in Parkinson's disease","volume":"52","author":"Li","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(01)00120-6","article-title":"3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis","volume":"93","author":"Li","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0320","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","article-title":"Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line","volume":"277","author":"Lotharius","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2017.09.033_b0325","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.033_b0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pscychresns.2016.12.011","article-title":"123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies","volume":"261","author":"Manabe","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/pr.59.2.1","article-title":"Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase","volume":"59","author":"Marchitti","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2017.09.033_b0340","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J Neurosci."},{"key":"10.1016\/j.brainres.2017.09.033_b0345","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/acs.analchem.5b04420","article-title":"Detection of free and protein-bound ortho-quinones by near-infrared fluorescence","volume":"88","author":"Mazzulli","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.brainres.2017.09.033_b0350","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.09.033_b0355","first-page":"40","article-title":"An autopsy case of pure autonomic failure with pathological features of Parkinson's disease","volume":"41","author":"Miura","year":"2001","journal-title":"Rinsho Shinkeigaku."},{"key":"10.1016\/j.brainres.2017.09.033_b0360","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3174\/ajnr.A3567","article-title":"Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy","volume":"34","author":"Miyoshi","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.brainres.2017.09.033_b0365","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1523\/JNEUROSCI.0519-06.2006","article-title":"Alpha-synuclein overexpression increases cytosolic catecholamine concentration","volume":"26","author":"Mosharov","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.033_b0370","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","article-title":"Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease","volume":"109","author":"Orimo","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0375","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/mds.20594","article-title":"Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2","volume":"20","author":"Orimo","year":"2005","journal-title":"Mov. Disord."},{"issue":"Suppl 2","key":"10.1016\/j.brainres.2017.09.033_b0380","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.parkreldis.2006.05.030","article-title":"Cardiac sympathetic denervation in Lewy body disease","volume":"12","author":"Orimo","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0385","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","article-title":"Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy","volume":"113","author":"Orimo","year":"2007","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.brainres.2017.09.033_b0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00401-008-0428-5","article-title":"Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication","volume":"116","author":"Orimo","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.033_b0400","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.09.033_b0405","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0410","doi-asserted-by":"crossref","first-page":"e15251","DOI":"10.1371\/journal.pone.0015251","article-title":"The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis","volume":"5","author":"Panneton","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2017.09.033_b0415","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1523\/JNEUROSCI.5456-13.2014","article-title":"Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum","volume":"34","author":"Pifl","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.033_b0420","doi-asserted-by":"crossref","first-page":"40699","DOI":"10.1038\/srep40699","article-title":"DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function","volume":"7","author":"Plotegher","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2017.09.033_b0425","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainres.2017.09.033_b0430","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1024\/0300-9831.79.3.152","article-title":"Antioxidant activity of olive polyphenols in humans: a review","volume":"79","author":"Raederstorff","year":"2009","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0435","first-page":"1769","article-title":"PET measurement of cardiac and nigrostriatal denervation in parkinsonian syndromes","volume":"47","author":"Raffel","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.brainres.2017.09.033_b0440","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13311-015-0404-4","article-title":"Neuronal glutathione content and antioxidant capacity can be normalized in situ by N-acetyl cysteine concentrations attained in human cerebrospinal fluid","volume":"13","author":"Reyes","year":"2016","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.brainres.2017.09.033_b0445","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2017.09.033_b0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2017.09.033_b0455","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/brain\/awh081","article-title":"Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication","volume":"127","author":"Singleton","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.09.033_b0460","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2017.09.033_b0465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","article-title":"Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease","volume":"240","author":"Suzuki","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2017.09.033_b0470","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp-2015-310686","article-title":"Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease","volume":"86","author":"Takahashi","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"Pt A","key":"10.1016\/j.brainres.2017.09.033_b0475","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2013.08.033","article-title":"Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus","volume":"76","author":"Taylor","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2017.09.033_b0480","article-title":"On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation","author":"Tello","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.brainres.2017.09.033_b0485","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10286-010-0068-4","article-title":"Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA)","volume":"20","author":"Tijero","year":"2010","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0490","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2012.08.001","article-title":"Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the alpha synuclein gene","volume":"19","author":"Tijero","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","article-title":"MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.brainres.2017.09.033_b0500","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.57.6.745","article-title":"Pure autonomic failure: a new case with clinical, biochemical, and necropsy data","volume":"57","author":"van Ingelghem","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.brainres.2017.09.033_b0505","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2017.09.033_b0510","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(25)28635-9","article-title":"Tetrahydropapaveroline: an alkaloid metabolite of dopamine in vitro","volume":"174","author":"Walsh","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2017.09.033_b0515","doi-asserted-by":"crossref","first-page":"e31522","DOI":"10.1371\/journal.pone.0031522","article-title":"Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: Implications for Parkinson's disease","volume":"7","author":"Wey","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2017.09.033_b0520","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.033_b0525","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000219640.59984.a7","article-title":"Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD","volume":"66","author":"Yoshita","year":"2006","journal-title":"Neurology"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:11:23Z","timestamp":1750943483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317304390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":105,"alternative-id":["S0006899317304390"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.09.033","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The heart of PD: Lewy body diseases as neurocardiologic disorders","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}